Perdagangan Novavax NVAX

Novavax diagram langsung

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Novavax news

2021 Mei 11, 13:20

US pre-market: selling unabated

2021 Mei 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 Mei 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Berita Terkini

Tampilkan lebih banyak
Sophia Claire 2025 Sep 30, 01:20

Potential Government Shutdown Threatens Key US Economic Data Delays

Noah Lee 2025 Sep 29, 14:20

Trump's 100% Tariff on Foreign Films: Hollywood's Future at Stake?

Liam James 2025 Sep 29, 06:20

Buffett Indicator Hits Record High: Market Valuation Concerns

Ava Grace 2025 Sep 29, 04:20

US Allies in Asia Balk at Trump's Investment Demands: South Korea and Japan Reassess Pledges

Liam James 2025 Sep 29, 03:20

US Treasury Yields Navigate Fed Uncertainty, Government Shutdown Risk

Emma Rose 2025 Sep 29, 02:20

Netanyahu-Trump Meeting: A New Gaza Peace Plan on the Table

Ava Grace 2025 Sep 29, 01:20

Fed Chair Succession: Waller vs. Hassett - Economists' Wishes vs. Political Reality

Liam James 2025 Sep 28, 06:20

Trump Mocks Powell with AI Image Amidst Rate Cut Debate

Info

Spread

0.07

Spread (%)

0.7392 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Senin

13:31 - 19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Kamis

13:31-19:59

Jumat

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

1551126784

Saham yang Beredar

162421645

Tanggal Penghasilan (Berikutnya)

2019-05-10

Hasil Div

2019-05-10

Tanggal Non-Dividen

Proyeksi tingkat dividen tahunan

0

Proyeksi hasil dividen tahunan

0

EPS

2.23

Pelajari lebih lanjut tentang instrumen ini

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

latest_education_articles

Tampilkan lebih banyak
Trustpilot